In this article:
Yahoo Finance Live’s Julie Hyman breaks down the decline in stock for BioNTech.
Video Transcript
JULIE HYMAN: A trending ticker you should keep an eye on, shares of Germany's BioNTech slumping as it forecast a worse-than-expected drop in its revenue this year amid drying-up demand for COVID vaccines. The group partnered up with Pfizer, remember, for its pandemic shot, but it's now warning revenue from COVID vaccines could drop to around 5 billion euros in 2023. The shares are down 4%.
We'll be right back.
